Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;32(8):1601-1615.
doi: 10.1111/pai.13589. Epub 2021 Jul 24.

Known and potential molecules associated with altered B cell development leading to predominantly antibody deficiencies

Affiliations
Review

Known and potential molecules associated with altered B cell development leading to predominantly antibody deficiencies

Parisa Amirifar et al. Pediatr Allergy Immunol. 2021 Nov.

Abstract

Predominantly antibody deficiencies (PADs) encompass a heterogeneous group of disorders characterized by low immunoglobulin serum levels in the presence or absence of peripheral B cells. Clinical presentation of affected patients may include recurrent respiratory and gastrointestinal infections, invasive infections, autoimmune manifestations, allergic reactions, lymphoproliferation, and increased susceptibility to malignant transformation. In the last decades, several genetic alterations affecting B-cell development/maturation have been identified as causative of several forms of PADs, adding important information on the genetic background of PADs, which in turn should lead to a better understanding of these disorders and precise clinical management of affected patients. This review aimed to present a comprehensive overview of the known and potentially involved molecules in the etiology of PADs to elucidate the pathogenesis of these disorders and eventually offer a better prognosis for affected patients.

Keywords: B-cell development; humoral immunity; immunoglobulin class switch recombination; inborn errors of immunity; predominantly antibody deficiencies; primary immunodeficiency.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2020;40(1):24-64.
    1. Smith T, Cunningham-Rundles C. Primary B-cell immunodeficiencies. Hum Immunol. 2019;80(6):351-362.
    1. Abolhassani H, Parvaneh N, Rezaei N, Hammarstrom L, Aghamohammadi A. Genetic defects in B-cell development and their clinical consequences. J Investig Allergol Clin Immunol. 2014;24(1):6-22.
    1. Azizi G, Yazdani R. Predominantly antibody deficiencies. Immunol Genet J. 2018;1:52-80.
    1. Azizi G, Abolhassani H, Asgardoon MH, et al. The use of immunoglobulin therapy in primary immunodeficiency diseases. Endocr Metab Immune Disord Drug Targets. 2016;16(2):80-88.

LinkOut - more resources